Status:
RECRUITING
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
Lead Sponsor:
University of Maryland, Baltimore
Conditions:
Pain
Virtual Reality
Eligibility:
All Genders
18-88 years
Phase:
NA
Brief Summary
This project examines, in chronic pain, the mechanisms of immersive virtual reality compared to the mechanisms of placebo hypoalgesia. The potential of developing new non-pharmacological premises for ...
Detailed Description
Virtual reality (VR) has been seen as an intervention for alleviating clinical chronic (and acute) pain. An approach to pain management utilizing VR presents opportunities for reducing pain and suffer...
Eligibility Criteria
Inclusion
- Age (18-88 years)
- English speaker (written and spoken)
- Temporal Mandibular Disorder (TMD) for at least 3 months
- TMD Grade Chronic Pain Scale (GCPS) ≥ 0
Exclusion
- Present or past degenerative neuromuscular disease
- Cardiovascular, neurological diseases, pulmonary abnormalities, kidney disease, liver disease, history of cancer within past 3 years
- Cervical pain (e.g. stenosis, radiculopathy)
- Any personal (or family first degree) history of mania, schizophrenia, or other psychoses
- Severe psychiatric condition (e.g. schizophrenia, bipolar disorders, autism) leading to hospitalization within the last 3 years.
- Use of Antipsychotics (e.g., Risperdal, Ability and clozaril)Lifetime alcohol/drug dependence or alcohol/drug abuse in past 3 months
- Pregnancy or breast feeding
- Color-blindness
- Impaired or uncorrected hearing
- Non-dominant hand
- Any facial trauma that has occurred in the last 6 weeks
- History of a severe facial trauma in the last 2-3 months
- Conditions that would interfere with the VR mask placement (e.g. trauma, burn, infection)
- Known history of severe motion sickness
- Non-removable head cover, artificial hair, certain types of braids or dreadlocks
- History of fainting
- History of angioedema
- Failed drug test (testing for opiates, cocaine, methamphetamines, and amphetamines)
Key Trial Info
Start Date :
April 9 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2026
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT06214923
Start Date
April 9 2024
End Date
November 30 2026
Last Update
June 29 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Luana Colloca
Baltimore, Maryland, United States, 21201-1512
2
University of Maryland
Baltimore, Maryland, United States, 21201-1512